Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
First Trust Capital Management L.P. CDAQF Compass Digital Acquisition Corp. 13G 9.99% 2y
Rock Springs Capital Management LP XLO Xilio Therapeutics, Inc. 13G 5.23% 2y
Blue Owl Capital Holdings LP PLRX Pliant Therapeutics, Inc. 13G 5.02% 2y
RTW INVESTMENTS, LP AKRO Akero Therapeutics, Inc. Common Stock 13G 6.4% 2y
CAT ROCK CAPITAL MANAGEMENT LP SEMR SEMrush Holdings, Inc. 13G 7.18% 2y
RTW INVESTMENTS, LP CLDX Celldex Therapeutics, Inc. 13G/A 6.3% 2y
ALLIANCEBERNSTEIN L.P. ATI Ati Inc 13G/A 2.5% 2y
TENOR CAPITAL MANAGEMENT Co., L.P. AERT Aeries Technology, Inc. 13G/A 5.5% 2y
Point72 Asset Management, L.P. GRTS Gritstone bio, Inc. Common Stock 13G/A 4.2% 2y
ENDEAVOUR CAPITAL ADVISORS INC CCB Coastal Financial Corp 13G/A 5.6% 2y
ArrowMark Colorado Holdings LLC MATX Matson, Inc. 13G 5.29% 2y
TANG CAPITAL MANAGEMENT, LLC RVPH Reviva Pharmaceuticals Holdings, Inc. 13G/A 9.99% 2y
BIOTECHNOLOGY VALUE FUND L P ANNX Annexon, Inc. 13G/A 8.9% 2y
PRICE T ROWE ASSOCIATES INC /MD/ VMRK Vivmark Residential 13G 5.2% 2y
P SCHOENFELD ASSET MANAGEMENT LP GAQ Generation Asia I Acquisition Limited Class A Ordinary Shares 13G/A 1.3% 2y
ARMISTICE CAPITAL, LLC NCPL Netcapital Inc. 13G 9.99% 2y
AQR CAPITAL MANAGEMENT LLC WELNF Integrated Wellness Acquisition Corp 13G/A 0% 2y
REDWOOD CAPITAL MANAGEMENT, LLC XPOF Xponential Fitness, Inc. 13G/A 6.51% 2y
TANG CAPITAL MANAGEMENT, LLC TARS Tarsus Pharmaceuticals, Inc. 13G/A 6.7% 2y
MOORE CAPITAL MANAGEMENT, LP FSR Fisker Inc. 13G/A 0% 2y
Andrew M. Brown KSCP Knightscope, Inc. 13G/A 1.1% 2y
Kent Lake Capital LLC ZIMV ZimVie Inc. Common Stock 13G/A 3.8% 2y
Ionic Ventures, LLC BTLN Brightline Interactive, Inc. 13G/A 4.9% 2y
ARMISTICE CAPITAL, LLC MBOT Microbot Medical Inc. 13G/A 4.99% 2y
ORBIMED ADVISORS LLC CRNX Crinetics Pharmaceuticals, Inc. 13G/A 2.5% 2y
Rock Springs Capital Management LP INZY Inozyme Pharma, Inc. Common Stock 13G/A 5.96% 2y
Andrew S. Hedden SCHL Scholastic Corp 13G 7.4% 2y
T. Rowe Price Investment Management, Inc. RVTY Revvity, Inc. 13G/A 12.7% 2y
ORION RESOURCE PARTNERS (USA) LP IAUX i-80 Gold Corp. 13G/A 16.6% 2y
Advent International, L.P. OLPX Olaplex Holdings, Inc. 13G/A 76.3% 2y
ALLIANCEBERNSTEIN L.P. SRCL Stericycle Inc 13G/A 8.6% 2y
Redmile Group, LLC KRYS Krystal Biotech, Inc. 13G/A 6.1% 2y
Shaolin Capital Management LLC MSSAF Metal Sky Star Acquisition Corp 13G/A 4.68% 2y
PRICE T ROWE ASSOCIATES INC /MD/ PTON Peloton Interactive, Inc. 13G/A 6% 2y
RTW INVESTMENTS, LP AXSM Axsome Therapeutics, Inc. 13G/A 9.5% 2y
Madison Avenue Partners, LP ONL Orion Properties Inc. 13G/A 5.4% 2y
Deep Track Capital, LP APGE Apogee Therapeutics, Inc. 13G/A 6.25% 2y
Mountain Crest Global Holdings LLC MCAG Mountain Crest Acquisition Corp. V 13G/A 63.59% 2y
Point72 Asset Management, L.P. BHVN Biohaven Ltd. 13G/A 3.2% 2y
FIDUCIARY MANAGEMENT INC /WI/ TRS Trimas Corp 13G 7.5% 2y
Select Equity Group, L.P. MTN Vail Resorts Inc 13G/A 7.2% 2y
GLAZER CAPITAL, LLC FNVT Finnovate Acquisition Corp. Class A Ordinary Shares 13G 6.93% 2y
ARMISTICE CAPITAL, LLC ERAS Erasca, Inc. 13G 5.36% 2y
BRUCE A. NORDSTROM JWN Nordstrom, Inc. 13G/A 15.55% 2y
SPROTT INC. SILV SilverCrest Metals Inc. Common Shares 13G/A 6% 2y
FIR TREE CAPITAL MANAGEMENT LP VHAQ Viveon Health Acquisition Corp. 13G/A 0.64% 2y
Radcliffe Capital Management, L.P. SCAQ Stratim Cloud Acquisition Corp. Class A Common Stock 13G/A 0% 2y
Cormorant Asset Management, LP GLUE Monte Rosa Therapeutics, Inc. 13G/A 0% 2y
T. Rowe Price Investment Management, Inc. BURL Burlington Stores, Inc. 13G/A 7.9% 2y
1 Main Capital Management, LLC ENZ Enzo Biochem, Inc. 13G/A 4.95% 2y